We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
17:00 - 18:00
T2
Head & neck cancer 3
Sabina Khan, United Kingdom;
Stefan Ana-Maria, Germany
Mini-Orals
Clinical
17:00 - 18:00
Validation and development of the 9th AJCC/UICC N classification for nasopharyngeal carcinoma in non-endemic regions of China: a multicenter study
Tong Jin, China
-2622
17:00 - 18:00
Concurrent capecitabine with hypofractionated palliative radiotherapy vs hypofractionated radiotherapy alone in head & neck cancer: a randomised trial
Shyama S, India
-663
17:00 - 18:00
A prospective study on risk model-based individualized irradiation of level IB region in nasopharyngeal carcinoma (Registration No. ChiCTR1800015880)
Jiai Hu, China
-3210
17:00 - 18:00
Multicenter validation of NTCP models for radiation-induced primary hypothyroidism in head and neck cancer survivors with long-term endocrine outcomes
James Chow, China
-1154
17:00 - 18:00
Proton therapy significantly reduces acute and late side effects in nasopharyngeal cancer: results from a prospective cohort study
Makbule Atasoyu, The Netherlands
-3978
17:00 - 18:00
Incidence of Second Primary Malignancies in Nasopharyngeal Carcinoma Survivors After Radiotherapy: A Population-Based Retrospective Study
Ruyu Xu, China
-3708
17:00 - 18:00
Qualitative analysis of the results of a prospective randomized clinical trial for AI-assisted GTV delineation in head and neck cancer
Jannis Rosenberger, Denmark
-3772
17:00 - 18:00
Randomized Trial on effect of prophylactic daily IV fluids in patients undergoing chemoradiotherapy for head and neck cancer
MEGHA T PHILIP, India
-5002